Malmud L S, Charkes N D, Littlefield J, Reilley J, Stern H, Rosenberg R, Fisher R S
J Nucl Med. 1979 Oct;20(10):1023-8.
This study was designed to evaluate quantitatively the mode of action of alginic acid compound (AAC) in the treatment of patients with symptomatic gastroesophageal reflux. Gastroesophageal scintigraphy using an orall administered Tc-99m sulfur colloid solution was used to demonstrate that AAC decreased significantly the gastroesophageal reflux index from (9.9 +/- 1.3) % to (6.5 +/- 0.8) % (p less than 0.05). No alteration of lower esophageal sphincter pressure was observed. After ACC was suitably labeled with Sr-87m, a dual-nuclide scintigraphic technique was used to show that most (greater than 75%) of the AAC was located in the upper half of the stomach in both normal subjects and patients with gastroesophageal reflux. In those subjects in whom reflux did occur after treatment with AAC, the Sr-87m-AAC refluxed into the esophagus preferentially compared with the liquid containing Tc-99m sulfur colloid. These findings suggest that AAC dimishes gastroesophageal reflux by means of its foaming, floating, and viscous properties.
本研究旨在定量评估海藻酸化合物(AAC)治疗有症状胃食管反流患者的作用方式。使用口服给予的锝-99m硫胶体溶液进行胃食管闪烁显像,结果表明AAC可使胃食管反流指数从(9.9±1.3)%显著降至(6.5±0.8)%(p<0.05)。未观察到食管下括约肌压力的改变。在用锶-87m对ACC进行适当标记后,采用双核素闪烁显像技术显示,在正常受试者和胃食管反流患者中,大多数(>75%)的AAC位于胃的上半部分。在用AAC治疗后发生反流的受试者中,与含有锝-99m硫胶体的液体相比,锶-87m-AAC优先反流至食管。这些发现提示,AAC通过其发泡、漂浮和粘性特性减少胃食管反流。